Tandem Diabetes (TNDM) Tops Q1 EPS by 8c, Revenues Beat; Offers FY21 Revenues Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. CVS

Go back to Tandem Diabetes (TNDM) Tops Q1 EPS by 8c, Revenues Beat; Offers FY21 Revenues Guidance Above Consensus

Tandem Diabetes Care Announces First Quarter 2021 Financial Results and Updated Full Year 2021 Sales Guidance

May 5, 2021 4:05 PM EDT

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2021 and updated its sales guidance for the year ending December 31, 2021.

First Quarter 2021 Highlights

In comparing the first quarter of 2021 to the same period of 2020:

Worldwide pump shipments increased 46 percent to 25,352 pumps from 17,378 pumps Sales increased 44 percent to $141.0 million from $97.9 million Gross margin improved to 52 percent of sales from 51 percent Operating margin... More